Co-Diagnostics Inc

NASDAQ:CODX

1.34

0.00 (+0.38%)

7:43:16 PM EDT: $1.38 +0.04 (+2.99%)

Market Cap (Intraday)	42.92M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.38 Million
Adjusted EPS	-$0.33

See more estimates

10-Day MA	$1.38
50-Day MA	$1.29
200-Day MA	$1.23

See more pivots

Co-Diagnostics Inc Stock, NASDAQ:CODX

2401 South Foothill Drive, Suite D, Salt Lake City, Utah 84109

United States of America

Phone: +1.801.438.1036

Number of Employees: 155

http://www.codiagnostics.com

Description

Co-Diagnostics, Inc. engages in the development and innovation of molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications. Its diagnostics systems enable very rapid, low-cost, molecular testing for organisms and genetic diseases by automating historically complex procedures in both the development and administration of tests. The company was founded by Brent C. Satterfield and Dwight Howard Egan on April 18, 2013 and is headquartered in Salt Lake City, UT.